Biotest (Schweiz) AG

The core activity of Biotest is the development, production and distribution of biological medicines, particularly in the fields of haematology, clinical immunology and intensive care medicine. The company covers the entire process and value chain, from research and development to the collection of blood plasma in its own collection centres and the production of plasma proteins and quality assurance.